Advertisement

November 16, 2026

Medtronic to Acquire Contego Medical

KEY TAKEAWAYS

  • Medtronic plans to acquire Contego Medical for $380 million, with additional contingent payments possible.
  • The transaction includes the recently FDA-approved Neuroguard IEP Direct system for transcarotid artery revascularization with integrated embolic protection.
  • The acquisition would expand Medtronic’s carotid revascularization and peripheral thrombectomy portfolios.

November 16, 2026—Medtronic announced its intention to acquire Contego Medical, a privately held medical device company focused on solutions for carotid artery disease and peripheral thrombectomy founded by Ravish Sachar, MD, and Jay Yadav, MD.

Medtronic stated it expects to complete the transaction in the third quarter of its fiscal year, subject to customary closing conditions. The acquisition is valued at $380 million with potential postacquisition payments.

The company highlighted that the planned acquisition includes Contego’s Neuroguard IEP Direct system for transcarotid artery revascularization system with integrated embolic protection (TCAR-IEP) in addition to flow reversal, which was recently approved by the FDA.

Beyond carotid revascularization, the acquisition includes Contego’s Excipio thrombectomy devices, which complement Medtronic’s Liberant thrombectomy system in the treatment of peripheral vascular disease, noted the press release.

According to the company, the acquisition will build on Medtronic’s exclusive United States distribution agreement with Contego, first announced in January 2025.

The company stated that the deal expands Medtronic’s portfolio of differentiated carotid technologies and is part of the company’s strategy of pursuing targeted investments that strengthen its core franchises.

“Contego was founded to address unmet needs in clinical practice by developing technologies designed to improve outcomes while simultaneously simplifying procedures,” commented Dr. Sachar in the Medtronic press release.

Dr. Sachar, Founder and Chief Executive Officer of Contego, continued, “Deepening our partnership with Medtronic is an exciting next chapter. We’re proud of our team and grateful to the physicians, study sites, employees, and investors who helped bring these technologies to patients.”

Advertisement


November 16, 2026

Sirtex Acquires FDA-Cleared Hourglass Vascular Plug

November 13, 2026

Siemens Healthineers to Become Healthineers


)